| Nov 11 |
Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development
|
| Nov 11 |
Geron to Participate in the Stifel 2024 Healthcare Conference
|
| Nov 10 |
Analysts Are Upgrading Geron Corporation (NASDAQ:GERN) After Its Latest Results
|
| Nov 9 |
Geron Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 8 |
Geron Corp (GERN) Q3 2024 Earnings Call Highlights: Strong Rytelo Launch and Strategic ...
|
| Nov 8 |
Geron Secures $250M Funding and Strong Q3 Sales
|
| Nov 8 |
Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value
|
| Nov 7 |
Geron (GERN) Q3 2024 Earnings Call Transcript
|
| Nov 7 |
Geron: A Post Earnings And Funding Announcement Assessment
|
| Nov 7 |
Geron Secures up to $375 Million in Funding with Royalty Pharma, Pharmakon Advisors
|
